Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers.

Journal of the National Comprehensive Cancer Network : JNCCN - 17 Apr 2024

Shevach Jeffrey W, Candelieri-Surette Danielle, Lynch Julie A, Hubbard Rebecca A, Alba Patrick R, Glanz Karen, Parikh Ravi B, Maxwell Kara N

Abstract excerpt

BACKGROUND: Germline genetic testing is a vital component of guideline-recommended cancer care for males with pancreatic, breast, or metastatic prostate cancers. We sought to determine whether there were racial disparities in germline genetic testing completion in this population. PATIENTS AND METHODS: This retrospective cohort study included non-Hispanic White and Black males with incident pancreatic, breast, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Breast Neoplasms, Male

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Healthcare Disparities

Share to Pancreatic Neoplasms

Share to Prostatic Neoplasms

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 38631387
DOI: 10.6004/jnccn.2023.7105
PMCID: PMC11361447

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers.PMID 38631387Read ↗

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.Semantic proximity Read ↗

The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer PatientsSemantic proximity Read ↗

Germline testing for prostate cancer: current state and opportunities for enhanced accessSemantic proximity Read ↗

Knowledge and attitudes toward prostate cancer germline genetic testing among Hispanic males.Semantic proximity Read ↗

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.Semantic proximity Read ↗

Assessing germline genetic testing patterns, awareness, and adherence to guidelines among lebanese prostate cancer patientsSemantic proximity Read ↗

Racial Disparities in Accessing Care along the Continuum of Cancer Genetic Service DeliverySemantic proximity Read ↗

Assessing Germline Genetic Testing Patterns, Awareness, and Adherence to Guidelines Among Lebanese Prostate Cancer PatientsSemantic proximity Read ↗

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate CancerSemantic proximity Read ↗

Socioeconomic and Demographic Barriers Associated with Delays in Pancreatic Cancer Germline Genetic TestingSemantic proximity Read ↗

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple SitesSemantic proximity Read ↗

Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.